苯二氮卓
焦虑
苦恼
社会心理的
医学
药方
精神科
心理干预
抗焦虑药
不利影响
抗焦虑药
催眠药
失眠症
重症监护医学
心理学
临床心理学
药理学
内科学
受体
出处
期刊:Addiction
[Wiley]
日期:2021-10-28
卷期号:117 (5): 1472-1482
被引量:9
摘要
Benzodiazepines continue to be prescribed widely in the management of patients with insomnia or anxiety disorders, despite the availability and acceptability of alternative pharmacological and psychological treatments. Many patients will experience adverse effects during treatment and considerable distress when the dosage is reduced and stopped. Management of benzodiazepine withdrawal includes measures to prevent the development of dependence, careful attention to underlying medical conditions, medication consolidation and gradual dosage reduction, accompanying psychological interventions, occasional prescription of concomitant medication, and relapse prevention with on-going support to address psychosocial stressors. There are needs for easier patient access to services with refined expertise and for further research to optimise strategies for preventing dependence and facilitating withdrawal.
科研通智能强力驱动
Strongly Powered by AbleSci AI